Has Kathleen Gordon, DO received payments from drug or device companies?

Yes. Drug and device makers reported $1,082,925 in general payments to Kathleen Gordon, DO across 1,022 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kathleen Gordon, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kathleen Gordon, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kathleen Gordon, DO

Internal Medicine · Johnston, RINPI 1861417354

Payments from drug & device makers

$1,082,925in general payments, 2019–2025

Across 1,022 payments — averaging $1059.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB SA$397K
AbbVie$345K
Sanofi US Services Inc.$98K
Pfizer$79K
Eli Lilly$56K
Sun Pharmaceutical Industries Inc.$52K
plus $55K from 50 others

$3,805in research payments, 2019–2025

Across 6 payments — averaging $634.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi US Services Inc.$4K
Eli Lilly$2

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB SA	92	$397,427
AbbVie(2 entities)	369	$345,251
Sanofi US Services Inc.	22	$98,423
Pfizer	59	$78,989
Eli Lilly	44	$56,189
Sun Pharmaceutical Industries Inc.	46	$51,562
Janssen Research & Development, LLC	15	$21,613
Arcutis Biotherapeutics, Inc.	11	$13,177
Amgen	15	$11,815
Vanda Pharmaceuticals Inc.	28	$2,270
AstraZeneca	53	$968
GSK	51	$894
Novo Nordisk	31	$611
Johnson & Johnson	30	$510
Nestle Healthcare Nutrition Inc.	15	$328
Exact Sciences	13	$266
Astellas Pharma US Inc	10	$256
Novartis	10	$220
Abbott	10	$196
E.r. Squibb & Sons, L.L.C.	4	$177
Teva Pharmaceuticals USA, Inc.	7	$153
Mylan Specialty L.p.	6	$125
Lundbeck LLC	6	$119
Lilly USA, LLC	6	$113
Antares Pharma, Inc.	5	$95
Sumitomo Pharma America, Inc.	4	$92
Tolmar, Inc.	6	$88
Phathom Pharmaceuticals, Inc.	4	$68
Sanofi	1	$63
Regeneron Healthcare Solutions, Inc.	3	$62
Sunovion Pharmaceuticals Inc.	5	$58
Mallinckrodt Hospital Products Inc.	2	$49
Amarin Pharma, Inc.	3	$45
Eisai Inc.	2	$44
Biohaven Pharmaceuticals, Inc.	2	$40
Idorsia Pharmaceuticals US Inc	2	$39
Biogen	2	$38
Boehringer Ingelheim	2	$37
Inspire Medical Systems, Inc.	2	$37
Dexcom, Inc.	2	$34
Otsuka America Pharmaceutical, Inc.	2	$33
Merck	2	$32
Kowa Pharmaceuticals America, Inc.	2	$31
Currax Pharmaceuticals LLC	2	$30
Bausch Health US, LLC	2	$30
Actelion Pharmaceuticals US, Inc.	1	$28
Biohaven Pharmaceutical Holding Company Ltd.	1	$28
Amneal Pharmaceuticals LLC	1	$27
Jazz Pharmaceuticals Inc.	1	$25
Acerus Pharmaceuticals Corporation	2	$24
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$20
Shield Therapeutics Inc	1	$18
Halozyme Inc	1	$16
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$15
Lucid Diagnostics Inc.	1	$14
Scpharmaceuticals Inc.	1	$13

How this compares

$1,082,925 in reported general payments places this provider in the 95th percentile of 808 internal medicine providers in Rhode Island.

See all internal medicine providers in Rhode Island →

Medicare billing

Part B allowed, 2024

$75,069

Medicare patients

307

Services billed

898

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Johnston

Stephanie DrainvilleJohnston$11K
Kiley ToderJohnston$7K
P Wilfredo CanchisJohnston$5K
David FriedEast Greenwich$37.2M
Gregory AllenCranston$12.2M
William BeliveauJohnson$962K
Scott WilsonCumberland$907K
Aaron SamuelsProvidence$751K
Frank D'alessandroLincoln$541K
Andrew HsuProvidence$409K

See the full list for Rhode Island →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →